Proteomics-informed, genome-edited CHO design increased productivity up to three-fold and titers two-fold, strengthening CLD for novel biologics and biosimilars. Extended culture robustness was ...
The Trade-off Between Physiological Authenticity and Experimental Convenience: Navigating the Cellular Foundation of ...
Researchers recently enhanced the titer of a cell line still in development to produce adenovirus viral vectors by 7.5-fold, and without the risk of also producing replication-competent adenoviruses ...
Successfully producing large quantities of biotherapeutics, including monoclonal antibodies and recombinant protein products, depends on robust and reliable cell line development (CLD). Issues that ...
On October 4, 1951, Henrietta Lacks died. But her cells didn't. Over 50,000,000 tons have since been produced worldwide.
Researchers at the Ribeirao Preto Blood Center and the Center for Cell-Based Therapy (CTC) conducted a study using the NK-92 cell line to test new models of chimeric antigen receptors (CARs) with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results